Breast cancer patients with BRCA1 mutation experience pCR after neoadjuvent chemother

[News]

Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) - the disappearance of all evidence of disease from the breast tissue and lymph nodes - regardless of disease stage after standard neoadjuvent chemotherapy, according to new research from The University of Texas MD Anderson Cancer Center.

More... (http://www.news-medical.net/news/20110907/Breast-cancer-patients-with-BRCA1-mutation-experience-pCR-after-neoadjuvent-chemotherapy.aspx)